Fearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of ...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as ...

Find insight on Novo Nordisk, product-specific tariffs, Pro Medicus and more in the latest Market Talks on Health Care.

The company also suffered from a clinical setback that sank its stock price. However, the stock now looks reasonably valued, ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...